Poly Medicure Ltd
NSE:POLYMED
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IN |
|
Poly Medicure Ltd
NSE:POLYMED
|
151.8B INR |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9.1T JPY |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.3B USD |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
30.4B CHF |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
122B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.6B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.9B CNY |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD |
Loading...
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.1B CHF |
Loading...
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.2T KRW |
Loading...
|
Market Distribution
| Min | -305 007.7% |
| 30th Percentile | 2.1% |
| Median | 5.8% |
| 70th Percentile | 11.6% |
| Max | 1 221 633.3% |
Other Profitability Ratios
Poly Medicure Ltd
Glance View
Poly Medicure Ltd., an Indian manufacturer of medical devices, is a compelling narrative of innovation driving tangible impact in healthcare. It embarked on its journey in the late 1990s, seizing on the escalating demand for high-quality medical consumables. The company carved its niche by producing a wide array of disposable medical devices like catheters, infusion therapy systems, and wound closure products, essential in medical facilities worldwide. By establishing a robust manufacturing infrastructure and leveraging economies of scale, Poly Medicure ensures competitive pricing while adhering to global quality standards. A dedication to research and development undergirds their operation, constantly pushing the envelope of modern medical technology. Revenue streams flow primarily from the sale of these innovative products to hospitals, healthcare institutions, and distributors across more than 100 countries. The company's strategic positioning in the industry is further reinforced by its commitment to sustainability and stringent adherence to regulatory compliance, which helps in sustaining long-term contracts and partnerships. The expansion of its product range and the adoption of automated manufacturing processes don't just meet but often forecast sector demands. By keeping its pulse on global health trends, Poly Medicure ensures not only stable growth in its financial graphs but also cements its authority as a cornerstone entity in the medical supplies marketplace.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Poly Medicure Ltd is 21.1%, which is above its 3-year median of 19.2%.
Over the last 3 years, Poly Medicure Ltd’s Net Margin has increased from 13.8% to 21.1%. During this period, it reached a low of 13.8% on Sep 30, 2022 and a high of 21.2% on Jun 30, 2025.